페프로민바이오
Irvine, US · 1 known investors
PeproMene Bio is a clinical-stage biotech company developing CAR-T cell immune therapies, including its BAFF-R targeting PMB-CT01 program, to treat B-cell cancers and autoimmune disorders. The therapy is aimed at patients with B-cell malignancies such as lymphomas and immune diseases.
Investors · 1
Competitors · 3
by search overlap
Builtinla12 shared keywordsBuilt In Los Angeles is the LA-focused edition of Built In, an online platform where tech professionals browse company profiles, job listings, and articles about the local startup and tech scene. It connects job seekers with employers and lets companies post jobs and recruit tech talent.
Orange County Business Council9 shared keywordsA promotional page for Orange County, California, describing the region's industries, lifestyle, weather, and economic resources to attract companies. It is a location/economic development marketing site rather than a startup or product company.
Amberstone Biosciences9 shared keywords
Companies competing with 페프로민바이오 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 페프로민바이오 do?
- PeproMene Bio is a clinical-stage biotech company developing CAR-T cell immune therapies, including its BAFF-R targeting PMB-CT01 program, to treat B-cell cancers and autoimmune disorders. The therapy is aimed at patients with B-cell malignancies such as lymphomas and immune diseases.
- Who are 페프로민바이오's investors?
- 페프로민바이오's investors include Solidus Investment.
- Where is 페프로민바이오 headquartered?
- 페프로민바이오 is headquartered in Irvine, US.